Published: 3/2/2022 10:22:06 AM

Inhalation Sciences: Breathing Optimism - Redeye

Redeye returns with a more detailed take on ISAB’s Q4’21 report. We are encouraged to see an improved commercial activity during the fourth quarter and continue to foresee a gradually increasing order intake during 2022.

Link to the analysis

Read more about Inhalation Sciences Sweden AB